Skip to main
XRAY
XRAY logo

DENTSPLY SIRONA (XRAY) Stock Forecast & Price Target

DENTSPLY SIRONA (XRAY) Analyst Ratings

Based on 24 analyst ratings
Hold
Strong Buy 17%
Buy 25%
Hold 54%
Sell 4%
Strong Sell 0%

Bulls say

Dentsply Sirona has experienced a modest increase in sales, with reported growth of 2.8% in Europe and notable contributions from Wellspect Healthcare, which achieved $81 million in revenue, reflecting an 8.6% increase. The firm's potential upside is bolstered by improving market conditions for implants, market share gains in clear aligners, and overall margin enhancements that may drive faster earnings per share (EPS) growth. Additionally, growth in the SureSmile segment showcases robust expansion, particularly in Europe, indicating effective execution and successful new product launches that contribute positively to the company’s overall outlook.

Bears say

Dentsply Sirona's financial performance revealed significant challenges, as the adjusted earnings per share (EPS) of $0.26 fell considerably short of the expected $0.43, primarily due to a substantial revenue loss attributed to the Byte product shutdown. The company faced an 8.3% decline in revenue from its connected technology solutions (CTS) segment, compounded by increasing operating expenses and lower gross margins, which negatively impacted overall profitability. Additionally, revenue within the orthodontics segment suffered a high-double-digit decline, further indicating vulnerability and raising concerns regarding future growth prospects amidst ongoing restructuring initiatives.

DENTSPLY SIRONA (XRAY) has been analyzed by 24 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 25% recommend Buy, 54% suggest Holding, 4% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DENTSPLY SIRONA and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DENTSPLY SIRONA (XRAY) Forecast

Analysts have given DENTSPLY SIRONA (XRAY) a Hold based on their latest research and market trends.

According to 24 analysts, DENTSPLY SIRONA (XRAY) has a Hold consensus rating as of Aug 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $37.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $37.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DENTSPLY SIRONA (XRAY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.